You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
In Nature this week: increased epigenetic upregulation of TET2 in Parkinson's disease, and more.
The head of the World Health Organization urges nations to join a global vaccine agreement, according to NPR.
According to ScienceInsider, a US ethics board has rejected most of the applications it reviewed for using human fetal cells in research.
The New York Times reports that pooling samples for COVID-19 testing isn't beneficial in much of the US because positive rates are too high.
In Genome Biology this week: analysis of tuberculosis samples from the 1600s, tool to detect variants affecting RNA-binding protein activity, and more.
Genomic analysis indicates New Zealand's new coronavirus cases likely came from either Australia or the UK, but exactly how it got to the country is not clear.
The Washington Post reports there were multiple introductions of SARS-CoV-2 into the capital region by the end of March 2020.
Mongabay reports on an effort to develop a map of chimpanzee genetic diversity.
In PNAS this week: epigenetic study of Kaposi's sarcoma-associated herpesvirus, non-coding variant prioritization tool, and more.
The Telegraph reports that the UK health secretary plans to replace Public Health England with a new health protection agency.
A saliva-based test for COVID-19 that got help from the National Basketball Association has received Emergency Use Authorization, according to the Wall Street Journal.
A new study suggests syphilis may have been circulating in Europe before Columbus returned from the Americas, Science reports.
In PLOS this week: chromosomal integration of human herpesvirus 6, gene expression predictions across populations, and more.
A new analysis suggests warming, not the arrival of humans, led to the extinction of the woolly rhinoceros thousands of years ago, the Economist reports.
The UK has ordered 60 million coronavirus vaccine doses from Novavax and 30 million doses from Janssen, according to the Guardian.
Chinese health officials uncovered SARS-CoV-2 viral RNA on imported frozen food, but the New York Times reports catching COVID-19 that way would be unlikely.
In Science this week: machine learning model predicts whether ion channel mutations will cause disease, and more.
The Newsroom reports New Zealand is using genomics to trace the origins of its new coronavirus outbreak.
The Wall Street Journal reports on the struggle to meet the demand for rapid COVID-19 testing.
According to Bloomberg, Moderna has a $1.5 billion vaccine deal with the US to provide 100 million doses.
In Nature this week: researchers in Canada sequence the genome of the black mustard plant Brassica nigra, and more.
According to ScienceInsider, the US National Academies of Science, Engineering, and Medicine is planning a study of racism in academic research.
The Washington Post writes that the approval in the US of a SARS-CoV-2 vaccine will be up to Peter Marks, a career official at the Food and Drug Administration.
NPR reports the US loan to Eastman Kodak to boost domestic pharmaceutical production is on pause following insider trading allegations.
In Cell this week: blood immune cell changes in COVID-19 patients and spatial transcriptomics in Alzheimer's disease.
The strain now accounts for about 80 percent of cases in Wales and Scotland, and about half of cases in England, the Guardian reports.
The Washington Post reports that US states and territories are seeking more funding for the distribution of SARS-CoV-2 vaccines.
A new study suggests that using CRISPR to edit human embryonic DNA can lead to the loss of whole chromosomes, as the Associated Press reports.
In Science this week: ancient dog genomes highlight long ties with humans, genomic analysis of 40,000-year-old early East Asian individual, and more.